Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;23:402-408

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hino, T.
Right arrow Articles by Brickman, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hino, T.
Right arrow Articles by Brickman, A. S.

Hypertension, Vol 23, 402-408, Copyright © 1994 by American Heart Association


ARTICLES

Parathyroid hormone analogues inhibit calcium mobilization in cultured vascular cells

T Hino, MD Nyby, M Fittingoff, ML Tuck and AS Brickman
Department of Endocrinology, Veterans Affairs Medical Center, Sepulveda, CA 91343.

Parathyroid hormone and parathyroid hormone-related protein lower blood pressure and relax contracted arteries. Parathyroid hormone also attenuates angiotensin II-induced vasoconstriction. To determine the cellular mechanism or mechanisms by which parathyroid hormone analogues antagonize pressor effects, we examined the effect of these peptides on angiotensin II-induced calcium mobilization in fura 2-AM-loaded cultured rat vascular smooth muscle cells. Either 100 nmol/L parathyroid hormone or parathyroid hormone-related protein significantly reduced the amount of calcium mobilized by 100 nmol/L angiotensin II. The attenuating effect of these peptides was mimicked by 10 mmol/L forskolin and 10 mmol/L isobutylmethylxanthine and was not dependent on the presence of extracellular calcium. This effect of the parathyroid hormone analogues was reduced when cells were pretreated with 100 mmol/L 2',5'-dideoxyadenosine, an adenylate cyclase inhibitor. Combined inhibition of cyclic nucleotide-dependent protein kinases eliminated the inhibitory effect of parathyroid hormone, whereas protein kinase C inhibition had no effect. Parathyroid hormone analogues decreased the amount of calcium released by inositol 1,4,5- trisphosphate in digitonin-permeabilized vascular smooth muscle cells. This effect was inhibited by treatment with 2',5'-dideoxyadenosine. These results suggest that these peptides attenuate inositol 1,4,5- trisphosphate-sensitive calcium mobilized by angiotensin II via an adenylate cyclase-dependent mechanism. This may be a mechanism by which acute administration of parathyroid hormone or parathyroid hormone- related peptide antagonizes vasoconstriction.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. J. Marchais, F. Metivier, A. P. Guerin, and G. M. London
Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease
Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2178 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato
Calcium Movements, Distribution, and Functions in Smooth Muscle
Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230.
[Abstract] [Full Text] [PDF]